Previous close | 492.02 |
Open | 495.45 |
Bid | 488.35 x 800 |
Ask | 488.74 x 1000 |
Day's range | 486.33 - 497.50 |
52-week range | 435.99 - 567.26 |
Volume | |
Avg. volume | 1,028,642 |
Market cap | 113.501B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 17.15 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 6.52 (1.33%) |
Ex-dividend date | 10 Sept 2024 |
1y target est | N/A |
ELV vs. GDRX: Which Stock Is the Better Value Option?
The sale of KR's specialty pharmacy to Elevance Health enables the company to focus on core strengths while enhancing patient care and supporting growth.
We recently made a list of Goldman Sachs’ Top Fund Manager Stock Picks: 25 Best Overweight Stocks. In this piece, we will look at where Elevance Health, Inc. (NYSE:ELV) ranks among the top Goldman Sachs’ fund manager stocks. With September and the third quarter of 2024 ending, Wall Street is now focused on two things. […]